{{Rsnum
|rsid=2194980
|Chromosome=12
|position=115064913
|Orientation=plus
|GMAF=0.3893
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 14.2 | 45.1 | 40.7
| HCB | 34.3 | 51.8 | 13.9
| JPT | 35.7 | 50.9 | 13.4
| YRI | 4.8 | 24.7 | 70.5
| ASW | 3.5 | 42.1 | 54.4
| CHB | 34.3 | 51.8 | 13.9
| CHD | 36.7 | 45.9 | 17.4
| GIH | 21.8 | 48.5 | 29.7
| LWK | 2.7 | 22.7 | 74.5
| MEX | 32.8 | 43.1 | 24.1
| MKK | 3.2 | 25.6 | 71.2
| TSI | 13.9 | 42.6 | 43.6
| HapMapRevision=28
}}
{{PMID Auto GWAS
|PMID=19043545
|Trait=Serum metabolites
|Title=Genetics Meets Metabolomics: A Genome-Wide Association Study of Metabolite Profiles in Human Serum
|RiskAllele=
|Pval=3E-7
|OR=NR
|ORtxt=NR
|OA=1
}}

{{PharmGKB
|RSID=rs2194980
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19043545; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genetics Meets Metabolomics: A Genome-Wide Association Study of Metabolite Profiles in Human Serum. (Initial Sample Size: 284 males; Replication Sample Size: NR); (Region: 12q24.21; Reported Gene(s): Intergenic; Risk Allele: rs2194980-?); (p-value= 0.0000003).This variant is associated with Serum metabolites.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740315
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2194980
|overall_frequency_n=86
|overall_frequency_d=128
|overall_frequency=0.671875
|n_genomes=46
|n_genomes_annotated=0
|n_haplomes=73
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}